Dechuan Kong

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Antiretroviral Therapy

Protein Protein

Men Who Have Sex With Men

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Takuya Tada, Yanzhao Zhang, Dechuan Kong, Michiko Tanaka, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells 13 (8) (2024)
Takuya Tada, Yanzhao Zhang, Dechuan Kong, Michiko Tanaka, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells 13 (8) (2024)
Takuya Tada, Yanzhao Zhang, Dechuan Kong, Michiko Tanaka, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells 13 (8) (2024)
Takuya Tada, Yanzhao Zhang, Dechuan Kong, Michiko Tanaka, Weitong Yao, Masanori Kameoka, Takamasa Ueno, Hideaki Fujita, Kenzo Tokunaga
Further Characterization of the Antiviral Transmembrane Protein MARCH8. Cells 13 (8) (2024)
Marne Azarias Da Silva, Pierre Nioche, Calaiselvy Soudaramourty, Anne Bull-Maurer, Mounira Tiouajni, Dechuan Kong, Ouafa Zghidi-Abouzid, Morgane Picard, Ana Mendes-Frias, Santa Cruz André, Alexandre Carvalho, Carlos Capela, Jorge Pedrosa, António Gil Castro, Paul Loubet, Albert Sotto, Laurent Muller, Jean-Yves Lefrant, Claire Roger, Pierre-Géraud Claret, Sandra Duvnjak, Tu-Anh Tran, Kenzo Tokunaga, Ricardo Silvestre, Pierre Corbeau, Fabrizio Mammano, Jérome Estaquier
Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti-SARS-CoV-2 antibodies in the absence of CXCL13. Science advances 9 (31) (2023)